<?xml version="1.0" encoding="UTF-8"?>
<ref id="B15">
 <mixed-citation publication-type="journal">
  <name>
   <surname>Tedesco</surname>
   <given-names>R</given-names>
  </name>
  <name>
   <surname>Shaw</surname>
   <given-names>AN</given-names>
  </name>
  <name>
   <surname>Bambal</surname>
   <given-names>R</given-names>
  </name>
  <name>
   <surname>Chai</surname>
   <given-names>D</given-names>
  </name>
  <name>
   <surname>Concha</surname>
   <given-names>NO</given-names>
  </name>
  <name>
   <surname>Darcy</surname>
   <given-names>MG</given-names>
  </name>
  <name>
   <surname>Dhanak</surname>
   <given-names>D</given-names>
  </name>
  <name>
   <surname>Fitch</surname>
   <given-names>DM</given-names>
  </name>
  <name>
   <surname>Gates</surname>
   <given-names>A</given-names>
  </name>
  <name>
   <surname>Gerhardt</surname>
   <given-names>WG</given-names>
  </name>
  <article-title>3-(1,1-dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, potent inhibitors of hepatitis C virus RNA-dependent RNA polymerase</article-title>
  <source>J Med Chem</source>
  <year>2006</year>
  <volume>49</volume>
  <fpage>971</fpage>
  <lpage>983</lpage>
  <pub-id pub-id-type="doi">10.1021/jm050855s</pub-id>
  <pub-id pub-id-type="pmid">16451063</pub-id>
 </mixed-citation>
</ref>
